Questions about the cost of EPCLUSA? We are here to help.

A live specialist can help you understand your specific insurance coverage, monthly co-pay, and other support available to help you afford EPCLUSA®.

Call 1-855-7-MYPATH (1-855-769-72841-855-769-7284) or enroll online here.

The amount a person pays for EPCLUSA depends on their individual circumstances and insurance plan. Below is a guide for what you can expect to pay.

Click on what best describes your coverage situation:

Typically a person taking EPCLUSA pays between $0 and $5 per month.

Eligible patients may pay as little as $5 per month with the EPCLUSA co-pay coupon. Terms and conditions apply. Check your eligibility here.

The list price of EPCLUSA is $24,920 per month. The list price is not typically the price a patient pays.

Typically a person taking EPCLUSA pays between $0 and $5 per month.

If you are a part of the Extra Help Program, you can expect to pay between $4 and $9 per month.

If you are unsure whether you qualify for the Extra Help Program and would like more information, click here.

The list price of EPCLUSA is $24,920 per month. The list price is not typically the price a patient pays.

Typically a person taking EPCLUSA pays between $4 and $9 per month.

Some state Medicaid programs offer even lower co-pays or eliminate co-pays altogether.

For more information about co-pays in your state, or whether you qualify for Medicaid, click here.

The list price of EPCLUSA is $24,920 per month. The list price is not typically the price a patient pays.

Support programs are available to help with insurance coverage and/or paying for prescription medicine.

Call EPCLUSA Support Path® at 1-855-7-MYPATH (1-855-769-72841-855-769-7284) to talk to a live specialist who can help with a benefits investigation, or enroll online here. You may be able to receive the medication free of charge. Restrictions apply.

The list price of EPCLUSA is $24,920 per month. The list price is not typically the price a patient pays.

The authorized generic of EPCLUSA is a lower-price option, made by ASEGUA, an affiliate of GILEAD. Click here for more information.

Please see Important Facts about EPCLUSA, including Important Warnings

Centers for Medicare & Medicaid Services. Announcement of calendar year (CY) 2019 Medicare Advantage capitation rates and Medicare Advantage and Part D payment policies and final call letter. https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Downloads/Announcement2020.pdf. April 1, 2019.

Derived from data sourced from Symphony Health (Patient Transaction Data) (October 2018-September 2019, accessed November 2019).

List price is also known as wholesale acquisition cost or WAC. WAC is listed as of January 1, 2024, for a 28-day supply of EPCLUSA.

U.S. Department of Health and Human Services. Medicaid and CHIP Overview for Assisters. https://marketplace.cms.gov/technical-assistance-resources/fast-facts-medicaid-chip.pdf. Updated 2018.

The information on this site is intended for audiences in the United States only. The content on this site may not apply to non-U.S. audiences as regulatory control, legal requirements and/or medical practices may vary in other countries.

BIKTARVY, the BIKTARVY Logo, DESCOVY, the DESCOVY Logo, EPCLUSA, the EPCLUSA Logo, TRODELVY, the TRODELVY Logo, GILEAD, the GILEAD Logo, ADVANCING ACCESS, and SUPPORT PATH are trademarks of Gilead Sciences, Inc., or its related companies. ASEGUA is a trademark of Asegua Therapeutics LLC. All other marks referenced herein are the property of their respective owners.